We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.1B
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
+15.08%
1 Year Est. Return
+4.68%
3 Year Est. Return
+8.24%
5 Year Est. Return
+32.95%
10 Year Est. Return
–
AUM
$1.85B
AUM Growth
-$122M
Cap. Flow
-$406M
Cap. Flow %
-21.88%
Top 10 Hldgs %
74.46%
Holding
121
New
44
Increased
20
Reduced
8
Closed
32

Top Buys

Rank Stock Value
1
TECD
Tech Data Corp
TECD
+$29.6M
2
TIF
Tiffany & Co.
TIF
+$26.6M
3
LPT
Liberty Property Trust
LPT
+$17.2M
4
AGN
Allergan plc
AGN
+$16.2M
5
MDCO
Medicines Co
MDCO
+$13.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$44.7M
2
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$13.8M
3
CBM
Cambrex Corporation
CBM
+$7.14M
4
WBC
WABCO HOLDINGS INC.
WBC
+$7.02M
5
GWR
Genesee & Wyoming Inc.
GWR
+$6.91M

Sector Composition

Rank Sector Weight
1 Healthcare 5.9%
2 Technology 2.24%
3 Consumer Discretionary 1.32%
4 Industrials 1.16%
5 Financials 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXE
51
DELISTED
Anixter International Inc
AXE
$1.84M 0.1%
+20,000
New +$1.62M
ZGNX
52
DELISTED
Zogenix, Inc.
ZGNX
$1.56M 0.08%
+30,000
New +$1.37M
ZGNX
53
PUT
DELISTED
Zogenix, Inc.
ZGNX
$1.56M 0.08%
+30,000
New +$1.37M
AXSM icon
54
CALL
Axsome Therapeutics
AXSM
$11.8B
$1.34M 0.07%
+13,000
New +$525K
GNW icon
55
Genworth Financial
GNW
$3.86B
$1.32M 0.07%
+300,000
New +$1.26M
GEN icon
56
Gen Digital
GEN
$16.1B
$1.28M 0.07%
50,000
-120,000
-71% -$2.93M
KDMN
57
DELISTED
Kadmon Holdings, Inc.
KDMN
$1.27M 0.07%
+280,000
New +$1.02M
TDS icon
58
Telephone and Data Systems
TDS
$3.91B
$1.22M 0.07%
+47,844
New +$1.17M
APTO
59
DELISTED
Aptose Biosciences, Inc.
APTO
$1.14M 0.06%
+446
New +$581K
CLF icon
60
PUT
Cleveland-Cliffs
CLF
$5.29B
$1.05M 0.06%
125,000
+110,000
+733% +$845K
IMMU
61
DELISTED
Immunomedics Inc
IMMU
$1M 0.05%
+47,500
New +$838K
IMMU
62
PUT
DELISTED
Immunomedics Inc
IMMU
$1M 0.05%
+47,500
New +$838K
BTAI icon
63
BioXcel Therapeutics
BTAI
$27.4M
$956K 0.05%
+4,088
New +$411K
KALV
64
DELISTED
KalVista Pharmaceuticals
KALV
$891K 0.05%
+50,000
New +$653K
DRNA
65
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$881K 0.05%
+40,000
New +$805K
DRRX
66
PUT
DELISTED
DURECT Corp
DRRX
$649K 0.04%
+17,130
New +$353K
ATEX icon
67
Anterix
ATEX
$1.96B
$557K 0.03%
+12,888
New +$525K
OYST
68
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$517K 0.03%
+21,147
New +$371K
PGNX
69
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$509K 0.03%
+100,000
New +$529K
CPE
70
CALL
DELISTED
Callon Petroleum Company
CPE
$483K 0.03%
10,000
– –
BMY.RT
71
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$461K 0.02%
+150,000
New +$390K
WVE icon
72
CALL
Wave Life Sciences
WVE
$1.12B
$401K 0.02%
+50,000
New +$1.23M
BKNG icon
73
Booking.com
BKNG
$141B
$314K 0.02%
3,825
– –
ENTXW
74
CALL
DELISTED
Entera Bio Ltd. Warrant
ENTXW
$64K ﹤0.01%
337,673
+13,001
+4% +$2.56K
NBR icon
75
CALL
Nabors Industries
NBR
$1.24B
$29K ﹤0.01%
+200
New +$21.1K
1 2
3
4 5

Similar funds

PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return

DLD Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, DLD Asset Management held 121 positions worth $1.85B, down 6.2% from $1.98B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

DLD Asset Management withdrew a net $406M in Q4 2019, closing 32 positions and reducing 8 holdings. Its most notable exit was Celgene Corp, an estimated $44.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5.9% of assets, up from 5.2% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, DLD Asset Management opened a new position in Tech Data Corp worth $33M.

  • DLD Asset Management's largest Q4 2019 buy was Tech Data Corp: 230,000 shares worth $33M.
  • DLD Asset Management added most to Allergan plc in Q4 2019, an estimated $16.2M increase.
  • DLD Asset Management's biggest Q4 2019 reduction was WABCO HOLDINGS INC., cutting an estimated $7.02M.
  • DLD Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $44.7M.
  • DLD Asset Management's ten largest holdings make up 74% of its $1.85B portfolio in Q4 2019.
  • DLD Asset Management opened 44 new positions and closed 32 in Q4 2019.
  • DLD Asset Management's portfolio value fell 6.2% quarter-over-quarter to $1.85B.

Based on DLD Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.